Speciality Generic Injectables

Biological E. Limited has invested in building an API facility and a Formulations facility at Shamirpet (outskirts of Hyderabad, India). Both these greenfield facilities are operational.

The API facility has about 72,000 square feet of built-up space. Presently, this facility is equipped for manufacturing Enoxaparin and Noscapine. The API facility has been inspected by the WHO. Currently, about 450 people work in the API facility.

The Formulations facility has about 102,000 square feet of built-up space. This facility is currently equipped for manufacturing injectable products in vials (liquid and lyophilized) and pre-filled syringes. The US FDA, WHO and Infarmed (Portugal), has inspected the Formulations facility. Currently, about 350 people work in the formulations facility.


The information on this website is intended for use only by residents of the United States of America. The product information on this site is provided for general information purposes only and is not intended to be a substitute for the actual approved product information. This information is neither medical advice nor a substitute for discussions with a qualified medical professional. The products listed are available only through prescription by a qualified medical professional. BE Pharmaceuticals Inc. and its affiliates shall not be responsible for the reliance on or use of any information contained herein. The reader understands and agrees to the foregoing.

I AgreeI Decline